Article Details

AstraZeneca's Enhertu included in China's state insurance reimbursement - TradingView

Retrieved on: 2024-11-28 20:39:31

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Enhertu included in China's state insurance reimbursement - TradingView. View article details on hiswai:

Excerpt

AstraZeneca's LSE:AZN blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an update from the ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up